Positional Obstructive Sleep Apnea
Conditions
Keywords
Positional therapy, MAD, Oral appliance, Sleep position trainer, POSA
Brief summary
OBJECTIVES: To evaluate the effect and cost-utility of a combination therapy of SPT+MAD compared with continuous positive airway pressure (CPAP) in patients with moderate positional obstructive sleep apnea (POSA). HYPOTHESIS: The SPT+MAD combination is more cost-effective and effective, in means of reduction of the apnea-hypopnea index (AHI), quality of life and compliance, compared with CPAP. STUDY DESIGN: A multicenter randomized clinical trial (RCT) will be performed with a follow-up of 12 months per patient. Patients will be randomized for CPAP or the combination SPT and MRA. All outcomes will be measured at baseline, month 3, 6 and 12. STUDY POPULATION: Patients diagnosed with moderate POSA according to polysomnography (PSG) results. INTERVENTION / STANDARD INTERVENTION TO BE COMPARED TO: The SPT trains POSA patients to sleep in non-supine positions, CPAP uses positive airway pressure to open the airway; MRA is an intra-oral prosthesis, which holds the mandible in a protrusive position, all to prevent effectively apneic events. OUTCOME MEASURES: AHI, compliance, quality-adjusted life year (QALY), direct and indirect costs, cardiovascular parameters, incremental cost-effectiveness ratio (ICER) SAMPLE SIZE / DATA ANALYSIS: 100 subjects in each treatment group, total of 200 patients. COST-EFFECTIVENESS ANALYSIS / BUDGET IMPACT ANALYSIS: The SPT is expected to improve the cost-effectiveness of overall treatment of POSA patients, and will save annually approximately 35-150 million euros.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* 18 years and older * Ability to speak, read and write Dutch * Ability to follow up * Diagnosis with symptomatic moderate OSA (15 \< AHI \< 30) * Diagnosis of 10 to 90% supine position during the night * AHI supine is 2 \> as high as AHI non-supine * Own a Windows PC and ability to install SPT connection software and upload research data * Expected to maintain current lifestyle (sports, medicine, diet etc.)
Exclusion criteria
* Many dental problems; insufficient teeth for wearing MRA * Medication used/ related to sleeping disorders * Central Sleep Apnea Syndrome * Night or shifting work * Severe chronic heart failure * Medical history of known causes of tiredness by day or severe sleep disruption (insomnia, PLMS, Narcolepsy) * Seizure disorder * Known medical history of mental retardation, memory disorders or psychiatric disorders * Shoulder, neck and back complaints * Reversible morphological upper airway abnormalities (e.g. enlarged tonsils) * Inability to provide informed consent * Simultaneous use of other treatment modalities to treat OSA * Previous treatment for OSA with MRA, CPAP or SPT * Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Apnea-hypopnea index (AHI) | change from baseline, after 3, 6 and 12 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Outcome of Quality of Life questionnaires | change from baseline, after 3, 6 and 12 months | EQ-5D |
| (Societal) costs of treatment | change from baseline, after 3, 6 and 12 months | iMTA Productivity Cost Questionnaire (iPCQ) |
| Therapy compliance | change from baseline, after 3, 6 and 12 months | Measurement of actual wearing time (in hours) per night |
| Cardiovascular parameters | change from baseline, after 3, 6 and 12 months | Systolic and diastolic blood pressure |
Countries
Belgium, Netherlands